The News Review:
- Coalition for 21st Century Medicine Endorses ‘Patient Access to …
- The New Face of Healing — riental Medicine Expert Releases …
- Jacobson to retire as leader of Vanderbilt University Medical …
- Stem cell research hits snag in Texas
- Corbis adds Science Faction
- Lilly schizophrenia drug fails clinical trial
- Top Canadian Prize Goes to Stanford Scientist Lucy Shapiro for …
Coalition for 21st Century Medicine Endorses ‘Patient Access to …
Additionally the bill will encourage continued innovation in the burgeoning and promising field of personalized medicine. Mapping the human genome has enabled revolutionary advances in understanding a wide variety of diseases and ushered in an era where treatments can be tailored to individual patients based on their DNA and the specific molecular character of their disease. Complex diagnostic laboratory tests make such “personalized medicine” possible. By understanding the molecular nature of disease these new technologies increasingly allow clinicians and patients to pick individualized treatment options rather than basing treatment choices on broad assessments of what works best for a population. Current Medicare regulations thwart access to these important tests and discourage innovation by requiring hospitals to act as middlemen in the billing process. Laboratories are required to bill hospitals and hospitals are required to bill Medicare. An access problem arises because hospitals are reluctant to assume the financial risk that the laboratory service will be covered and reimbursed by Medicare.
The New Face of Healing — riental Medicine Expert Releases …
MarketWatch (press release)
Suzuki later moved to the United States in 1972 and graduated from Sawyer College. He went on to receive a B.
Jacobson to retire as leader of Vanderbilt University Medical …
Vanderbilt University News
Balser’s appointment as vice chancellor is subject to approval by the university’s. "Harry and Jeff have made a formidable team as senior leaders at the Medical Center and Harry has mentored and prepared Jeff for this new role" Zeppos said.
Stem cell research hits snag in Texas
“Many Texans have moral concerns about this type of experimentation on human life. ”Stand-alone bills in previous legislative sessions that would have prohibited embryonic stem cell research and that would have allotted special funding for such research failed to pass. Meanwhile Baylor College of Medicine and University of Texas Health Science Center at Houston have worked with National Institutes of Health-approved stem cells lines for years. Future of medicineStem cell research is considered by many researchers to be the future of medicine producing cures for a host of ailments by replacing diseased tissue with newly grown tissue. It involves adult stem cells whose potential to morph into other cell and tissue types is just now being tapped; and embryonic stem cells the gold standard for such transformative capability. Because embryos must be killed to obtain the stem cell embryonic stem cell research is controversial. President George W.
Related from Advertisingmonster: Advertising on BR
Corbis adds Science Faction
“rganizations looking to harness the power of imagery in their communications will find that the outstanding Science Faction collection helps convey their concepts more beautifully and effectively. “Corbis’ customers will appreciate the premium nature and extensive range of our scientific imagery” said Roger Ressmeyer CE and Founder Science Faction. “We’re overjoyed to be working with Corbis to distribute our collections globally. It’s a perfect fit.
Lilly schizophrenia drug fails clinical trial
Earlier tests in about 200 patients had shown that the drug worked quickly and safely without resulting in weight gain a much-criticized side effect of its top-selling anti-psychotic drug Zyprexa. The earlier trial also showed that the drug was effective in treating hallucinations delusions social withdrawal and apathy. The findings had been published in the journal Nature Medicine and attracted widespread attention in the psychiatric research world. Patients who took the drug in the earlier trial showed no weight increase nor did they exhibit adverse effects commonly associated with many schizophrenia medications such as involuntary movements or muscle stiffness. In the latest trial however the results fell short of the mark. Lilly tested the drug on 393 patients for four weeks. The drug failed to outperform Zyprexa.
Top Canadian Prize Goes to Stanford Scientist Lucy Shapiro for …
Business Wire (press release)
“Lucy Shapiro has spent her career at the leading edge of developmental biology exploiting a simple bacterial model to forge creative new research directions and yield novel insights about cell differentiation that are applicable to higher organisms” said Jeremy M. Berg PhD director of the National Institutes of Health’s National Institute of General Medical Sciences which has funded Shapiro’s research since 1986. Shapiro is currently the director of the Beckman Center for Molecular and Genetic Medicine. She has been a faculty member at Stanford since 1989 when she founded the School of Medicine’s new Department of Developmental Biology. Science seems a good match for the artist-turned-researcher who still enjoys painting watercolor portraits. “Lucy is always doing something and always in a hurry” said her Stanford colleague Stanley Falkow PhD the Robert W.